The stock of Sigachi Industries tanked 6.88 per cent, Shilpa Medicare dropped 4.92 per cent, Suven Life Sciences declined ...

Hepatitis B is the most widespread serious liver infection globally, caused by the hepatitis B virus (HBV), which targets and ...

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

Indian pharma stocks fell sharply today, with Sigachi Industries leading the decline after reports of potential US tariffs on ...

The chronic hepatitis B market size is predicted to surge owing to the increasing prevalence of the disease globally and rising awareness about early diagnosis and treatment. Advances in antiviral ...

Nagpur: Tragedy struck a pharma company's unit in Nagpur district on Tuesday when a blast occurred in a glass line reactor, ...

Generic Drugs Market Size to Reach USD 769.52 Billion by 2033 | Says Cervicorn ConsultingThe generic drugs market size is ...

Sigachi Industries' shares slipped 8.19% to Rs 54.05  on BSE.  Dishman Carbogen Amcis shares fell 5% to Rs  260.55 against ...

Based in Kuala Lumpur, Aman brings over two decades of HR experience across industries like finance and pharma. To him, ...

James Moss, the director of cyber investigations at law firm Addleshaw Goddard, told Sky News the ICO's fine was "about as ...

A new biotech has come roaring to life in Wales with a $140 million series A and a lead candidate ready for phase 2 trials in ...